Sale!

CLDN16 Gene Hypomagnesemia Type 3 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The CLDN16 Gene Hypomagnesemia Type 3 Genetic Test is a specialized diagnostic examination available at DNA Labs UAE, designed to identify mutations in the CLDN16 gene. These mutations are associated with Familial Hypomagnesemia with Hypercalciuria and Nephrocalcinosis (FHHNC) type 3, a rare inherited condition characterized by low levels of magnesium in the blood, increased levels of calcium in the urine, and the potential for kidney stone formation and renal impairment.

This test is critical for individuals displaying symptoms of the disorder or those with a family history of FHHNC, as early detection can aid in managing symptoms and preventing severe kidney complications. The process involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed for specific genetic alterations in the CLDN16 gene.

At DNA Labs UAE, the cost for the CLDN16 Gene Hypomagnesemia Type 3 Genetic Test is set at 4400 AED. This price reflects the comprehensive nature of the test, from the collection of the sample to the detailed genetic analysis and the provision of a conclusive report. The results from this test can provide invaluable information for affected individuals and their families, guiding treatment plans and informing about the risk of passing the condition on to future generations.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CLDN16 Gene Hypomagnesemia type 3 Genetic Test

Components:

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test type: Metabolic Disorders

Doctor: General Physician

Test Department: Genetics

Pre Test Information:

Clinical History of Patient who is going for CLDN16 Gene Hypomagnesemia type 3 NGS Genetic DNA Test

A Genetic Counselling session to draw a pedigree chart of family members affected with Hypomagnesemia type 3

Test Details:

The CLDN16 gene is associated with a condition called hypomagnesemia type 3. Hypomagnesemia is a disorder characterized by abnormally low levels of magnesium in the blood. The CLDN16 gene provides instructions for producing a protein called claudin-16, which is involved in the reabsorption of magnesium in the kidneys.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes, including the CLDN16 gene. This type of testing can identify specific changes or mutations in the CLDN16 gene that may be causing hypomagnesemia type 3.

By analyzing the CLDN16 gene using NGS, healthcare professionals can determine if there are any genetic variations or mutations that are associated with hypomagnesemia type 3. This information can be helpful in diagnosing the condition and guiding treatment decisions.

It’s important to note that genetic testing for hypomagnesemia type 3 is typically done in conjunction with other diagnostic tests, such as blood tests to measure magnesium levels and kidney function. A healthcare professional will be able to provide more information and guidance on the specific genetic testing process and its implications.

Test Name CLDN16 Gene Hypomagnesemia type 3 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Metabolic Disorders
Doctor General Physician
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for CLDN16 Gene Hypomagnesemia type 3 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Hypomagnesemia type 3
Test Details

The CLDN16 gene is associated with a condition called hypomagnesemia type 3. Hypomagnesemia is a disorder characterized by abnormally low levels of magnesium in the blood. The CLDN16 gene provides instructions for producing a protein called claudin-16, which is involved in the reabsorption of magnesium in the kidneys.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes, including the CLDN16 gene. This type of testing can identify specific changes or mutations in the CLDN16 gene that may be causing hypomagnesemia type 3.

By analyzing the CLDN16 gene using NGS, healthcare professionals can determine if there are any genetic variations or mutations that are associated with hypomagnesemia type 3. This information can be helpful in diagnosing the condition and guiding treatment decisions.

It’s important to note that genetic testing for hypomagnesemia type 3 is typically done in conjunction with other diagnostic tests, such as blood tests to measure magnesium levels and kidney function. A healthcare professional will be able to provide more information and guidance on the specific genetic testing process and its implications.